President Recep Tayyip Erdoğan announced that critical drugs derived from blood will be produced in Turkey through the Protürk project. Erdoğan stated that with this initiative, Turkey will be included among the countries producing critical drugs from plasma.
The announcement stood out as a significant step highlighting domestic production capacity in the health sector. The project is particularly noted for aiming to reduce dependency on foreign sources in plasma-based drug production.
Erdoğan's remarks brought the issue of producing critical drugs domestically back into focus. Within this context, the project is regarded as a notable development in health technologies and the pharmaceutical industry.